ALT Q1 2022 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$353M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$32,000-96.2% YoY

Gross Profit

-$17M-52662.5% margin

Operating Income

-$19M-60934.4% margin

Net Income

-$19M-60718.8% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

-99.0%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$206M

Total Liabilities

$21M

Stockholders' Equity

$185M

Cash & Equivalents

$180M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32,000	$838,000	-96.2%
Gross Profit	-$17M	-$10M	-65.9%
Operating Income	-$19M	-$15M	-31.2%
Net Income	-$19M	-$15M	-30.7%